Somnomed

Somnomed PEG

The PEG Ratio (Price/Earnings-to-Growth) of Somnomed (SOM.AX) as of Oct 31, 2026 is -0.93. In the previous year, PEG Ratio (Price/Earnings-to-Growth) was -0.25 — a change of 279.23% (lower).

PEG

-0.93

YoY

279.23%

Last updated:

PEG Ratio (Price/Earnings-to-Growth) of Somnomed is 2026 -0.93 . PEG Ratio (Price/Earnings-to-Growth) of Somnomed was 2025 -0.25 . It decreases by 279.23% lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Somnomed Stock analysis

What does Somnomed do? SomnoMed Ltd is a leading medical technology company based in Sydney, Australia. It was founded in 2004 and specializes in the development and distribution of medical devices for the treatment of sleep apnea and bruxism. Somnomed is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Somnomed stock

PEG Ratio (Price/Earnings-to-Growth) of Somnomed is -0.93 in 2026.

PEG Ratio (Price/Earnings-to-Growth) of Somnomed changed from -0.25 to -0.93, representing a 279.23% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of PEG Ratio (Price/Earnings-to-Growth) Somnomed since 2006 – with annual values, charts, and detailed analysis.

The PEG ratio adjusts the P/E ratio by the expected earnings growth rate. A PEG below 1 may indicate an undervalued stock relative to its growth potential.

PEG = P/E Ratio / Expected Annual EPS Growth Rate

To evaluate PEG Ratio (Price/Earnings-to-Growth)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for PEG Ratio (Price/Earnings-to-Growth).

A 'good' varies by industry and company stage. On Eulerpool, you can compare PEG Ratio (Price/Earnings-to-Growth)'s Somnomed with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Somnomed

All Key Metrics — Somnomed